Boston Trust Walden’s Cohen & Steers CNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.9M Sell
558,433
-73,670
-12% -$4.81M 0.29% 127
2025
Q4
$39.7M Sell
632,103
-280,512
-31% -$18.2M 0.3% 127
2025
Q3
$59.9M Sell
912,615
-10,280
-1% -$753K 0.44% 85
2025
Q2
$69.5M Buy
922,895
+11,464
+1% +$881K 0.5% 70
2025
Q1
$73.1M Sell
911,431
-9,152
-1% -$781K 0.53% 64
2024
Q4
$85M Buy
920,583
+1,132
+0.1% +$112K 0.6% 50
2024
Q3
$88.2M Sell
919,451
-18,346
-2% -$1.56M 0.61% 44
2024
Q2
$68M Buy
937,797
+9,960
+1% +$708K 0.5% 66
2024
Q1
$71.3M Sell
927,837
-3,973
-0.4% -$284K 0.51% 68
2023
Q4
$70.6M Buy
931,810
+5,450
+0.6% +$328K 0.53% 61
2023
Q3
$58.1M Buy
926,360
+39,759
+4% +$2.52M 0.49% 70
2023
Q2
$51.4M Buy
886,601
+35,995
+4% +$2.1M 0.42% 86
2023
Q1
$54.4M Buy
850,606
+28,231
+3% +$1.97M 0.47% 71
2022
Q4
$53.1M Sell
822,375
-2,374
-0.3% -$149K 0.47% 69
2022
Q3
$51.7M Buy
824,749
+16,316
+2% +$1.17M 0.51% 60
2022
Q2
$51.4M Buy
808,433
+8,950
+1% +$677K 0.49% 68
2022
Q1
$68.7M Buy
799,483
+49,239
+7% +$4.08M 0.57% 52
2021
Q4
$69.4M Buy
750,244
+659
+0.1% +$61K 0.56% 48
2021
Q3
$62.8M Buy
749,585
+7,377
+1% +$625K 0.56% 52
2021
Q2
$60.9M Buy
742,208
+101,728
+16% +$7.34M 0.54% 52
2021
Q1
$41.8M Buy
640,480
+32,055
+5% +$2.19M 0.41% 80
2020
Q4
$45.2M Buy
608,425
+2,631
+0.4% +$174K 0.48% 62
2020
Q3
$33.8M Buy
605,794
+177,954
+42% +$11M 0.42% 70
2020
Q2
$29.1M Sell
427,840
-17,380
-4% -$1.05M 0.39% 75
2020
Q1
$20.2M Sell
445,220
-103,448
-19% -$6.54M 0.32% 94
2019
Q4
$34.4M Buy
548,668
+14,545
+3% +$920K 0.4% 77
2019
Q3
$29.3M Buy
534,123
+80,632
+18% +$4.27M 0.37% 82
2019
Q2
$23.3M Buy
453,491
+1,860
+0.4% +$91.2K 0.3% 98
2019
Q1
$19.1M Buy
451,631
+2,425
+0.5% +$94.3K 0.26% 116
2018
Q4
$15.4M Sell
449,206
-7,161
-2% -$265K 0.25% 118
2018
Q3
$18.5M Sell
456,367
-13,104
-3% -$549K 0.26% 116
2018
Q2
$19.6M Buy
469,471
+657
+0.1% +$26.4K 0.29% 111
2018
Q1
$19.1M Sell
468,814
-24,219
-5% -$1.02M 0.29% 112
2017
Q4
$23.3M Sell
493,033
-8,881
-2% -$391K 0.34% 91
2017
Q3
$19.8M Sell
501,914
-2,870
-0.6% -$114K 0.31% 103
2017
Q2
$20.5M Sell
504,784
-109,566
-18% -$4.37M 0.33% 98
2017
Q1
$24.6M Sell
614,350
-54,147
-8% -$1.96M 0.38% 97
2016
Q4
$22.5M Sell
668,497
-171,613
-20% -$6.27M 0.35% 115
2016
Q3
$35.9M Sell
840,110
-511
-0.1% -$21.6K 0.59% 47
2016
Q2
$34M Sell
840,621
-37,286
-4% -$1.47M 0.58% 49
2016
Q1
$34.2M Buy
877,907
+202,392
+30% +$6.37M 0.59% 49
2015
Q4
$20.6M Sell
675,515
-142,034
-17% -$4.27M 0.38% 95
2015
Q3
$22.4M Sell
817,549
-35,846
-4% -$1.1M 0.37% 106
2015
Q2
$29.1M Buy
853,395
+29,407
+4% +$1.11M 0.44% 91
2015
Q1
$33.7M Sell
823,988
-26,813
-3% -$1.14M 0.5% 81
2014
Q4
$35.8M Sell
850,801
-43,314
-5% -$1.81M 0.53% 74
2014
Q3
$34.4M Sell
894,115
-39,529
-4% -$1.68M 0.53% 68
2014
Q2
$40.5M Sell
933,644
-13,809
-1% -$565K 0.59% 65
2014
Q1
$37.8M Sell
947,453
-19,894
-2% -$752K 0.56% 71
2013
Q4
$38.8M Sell
967,347
-64,766
-6% -$2.49M 0.57% 70
2013
Q3
$36.4M Sell
1,032,113
-18,768
-2% -$649K 0.56% 76
2013
Q2
$35.7M Buy
+1,050,881
New +$39.9M 0.58% 70

Other funds holding CNS

Boston Trust Walden's CNS Position: Q1 2026 in Review

Boston Trust Walden reduced its Cohen & Steers (CNS) stake by 12% in Q1 2026, selling an estimated $4.81M and leaving 558,433 shares worth $34.9M. The position accounts for 0.29% of the portfolio, ranked #127.

Boston Trust Walden first reported a position in CNS in Q2 2013 and has held it in 52 quarters since. The position peaked at $88.2M in Q3 2024. 294 funds tracked by Wall St. Rank hold CNS as of Q1 2026.

  • Boston Trust Walden held 558,433 shares of Cohen & Steers worth $34.9M as of Q1 2026.
  • Boston Trust Walden sold 73,670 Cohen & Steers shares in Q1 2026, an estimated $4.81M.
  • Cohen & Steers made up 0.29% of Boston Trust Walden's portfolio in Q1 2026, its #127 holding.
  • Boston Trust Walden first reported a position in Cohen & Steers in Q2 2013 and has held it in 52 quarters since.
  • Boston Trust Walden's Cohen & Steers position peaked at $88.2M in Q3 2024.
  • 294 funds tracked by Wall St. Rank held Cohen & Steers as of Q1 2026.

Based on Boston Trust Walden's 13F filing for Q1 2026, filed 24 Apr 2026.